Sign In
Buy UNH
$400.96
+1.43 (+0.358%)
At Close: Jun 18, 2026
Kala''s dry eye drug Eysuvis gets coverage by UnitedHealthcare Commercial, Cigna Medicare
02:21pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Kala Pharmaceuticals (KALA) said that UnitedHealthcare (UNH) added dry eye disease therapy Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its…
Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare
01:00pm, Tuesday, 08'th Mar 2022 GlobeNewswire
-- Expands Commercial Coverage to 118 million lives and Medicare Coverage to 7.1 million lives -- ARLINGTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that UnitedHealthcare, one of the largest commercial health care plans in the United States, covering approximately 13 million lives, has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies effective March 2022. EYSUVIS now has coverage for approximately 118 million lives, or 70% of all commercial lives.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
11:20am, Monday, 07'th Mar 2022 Zacks Investment Research
Sector ETF report for IHF
3 Top Healthcare Stocks to Buy for March
03:45pm, Sunday, 06'th Mar 2022 The Motley Fool
These three stocks are solid value picks in different areas of healthcare.
IUSV: A Decent Value ETF, But It Could Be Better
07:15am, Sunday, 06'th Mar 2022
IUSV: A Decent Value ETF, But It Could Be Better
UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
01:00pm, Saturday, 05'th Mar 2022 Investor''s Business Daily
UnitedHealth and Vertex Pharmaceuticals are among five medical stocks with healthy action in a weak market.
How to Turn $100,000 Into $1 Million in 25 Years
12:24pm, Saturday, 05'th Mar 2022 The Motley Fool
The process isn't hard; it's the discipline that will require a big commitment.
How to Turn $100,000 Into $1 Million in 25 Years
07:24am, Saturday, 05'th Mar 2022
The process isn't hard; it's the discipline that will require a big commitment.
Teladoc Health (TDOC) Tumbling: Is it Healthy for Your Portfolio?
05:37pm, Friday, 04'th Mar 2022 Zacks Investment Research
For this year, Teladoc Health (TDOC) projects total visits in the band of 18.5-20 million, indicating a rise from the 2021 level of 15.4 million.
Ruane Cunniff's Sequoia Fund 2021 Annual Report
03:10pm, Friday, 04'th Mar 2022
Dear Shareholder:
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
03:00pm, Friday, 04'th Mar 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
United Health Foundation to Provide $1M to Support Relief Efforts in Ukraine
01:00pm, Friday, 04'th Mar 2022 Business Wire
MINNETONKA, Minn.--(BUSINESS WIRE)--The United Health Foundation, part of UnitedHealth Group, today announced a $1 million donation to support relief efforts in Ukraine.
Investors Should Keep Calm, Carry On, and Hold These 2 Stocks for Safety
11:00am, Wednesday, 02'nd Mar 2022
These are consistent, profit-generating businesses that you can invest in for the long haul.
The Most-Sold Guru Stocks of the 4th Quarter
05:47pm, Tuesday, 01'st Mar 2022
In the fourth quarter of 2021, which ended on Dec. 31, a Santa Claus rally driven by higher-than-expected retail sales helped push U.S. stock indexes to new record highs. The S&P 500 surpassed 4,790,
Medical Giant CEO Wins 2022 NCAA Award, Looks To Score Breakout
07:16pm, Monday, 28'th Feb 2022 Investor''s Business Daily
Joining UnitedHealth among new buys by top funds, Anthem nears high as its CEO Gail Boudreaux scores 2022 NCAA honors.
